court filing

HISA, FTC Link Grim Headlines to HBPA's Desire for 'Status Quo'

In two separate court filings Thursday, the Horseracing Integrity and Safety Act (HISA) Authority and the Federal Trade Commission (FTC) both sharply criticized the National Horsemen's Benevolent and Protective Association (NHBPA)'s decision to seek an injunction that would delay the May 22 implementation of the Anti-Doping and Medication Control (ADMC) program. What stood out was that neither the HISA Authority nor the FTC shied from trying to link the NHBPA's desire to maintain the "status quo" to the grim headlines that have dominated the sport over the past week. "Seven...

[ Read More ]
HISA Authority: Plaintiffs In La Lawsuit Have 'No Right' to Add New Parties

The Horseracing Integrity and Safety Act (HISA) Authority reiterated to a judge on Monday a belief that the plaintiffs in the federal lawsuit spearheaded by the state of Louisiana have "no right" to expand the scope of their complaint by letting new entities join the nine-month-old case in United States District Court (Western District of Louisiana). "Plaintiffs characterize their joinder of new parties as a 'routine amendment,'" the Apr. 3 court filing stated. "But they do not dispute that the purpose of their amendment is to transform the preliminary injunction...

[ Read More ]
Feds: Fishman Still Selling PEDs Even as Trial Date Looms

An employee of Florida veterinarian Seth Fishman last week permitted Federal Bureau of Investigation (FBI) agents to search her workplace, and the inside tip has allegedly yielded evidence that Fishman is still selling purportedly performance-enhancing drugs (PEDs) while awaiting an expected January start to his trail in the international racehorse doping conspiracy case. "Remarkably, despite having been arrested in October 2019 and indicted in 2020 in connection with his sale of misbranded and adulterated drugs designed to be 'untestable' by various antidoping authorities, Fishman apparently persists in touting the efficacy...

[ Read More ]
X

Never miss another story from the TDN

Click Here to sign up for a free subscription.